Delivery Order SPE2DB24D2205-SPE2DB25FEEEL
Award Date 6/27/25
Potential Completion Date 6/30/25
Potential Value $37K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,605.35 on August 20, 2025, for the supply of RINVOQ ER 30 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 21, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract...
- The Defense Logistics Agency awarded a $29,017.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on December 4, 2025, with completion targeted for December 5, 2025. This is a non-set-aside competitive award to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The order represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply contract vehicle with DLA....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $30.2K to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on December 18, 2025, with an ultimate completion date of December 19, 2025. This firm fixed price delivery order, which was competitively awarded with no set-aside designation, represents a fulfillment against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX). The contract...
- The Defense Logistics Agency awarded a $6,558.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on December 8, 2025, with completion targeted for December 9, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for RINVOQ ER 30 mg tablets in a quantity of 30 units, with a ceiling value of $9,594.18. This is a firm fixed-price, non-set-aside delivery order that represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $8,496.41 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count unit dose packaging) on October 29, 2025, with completion required by October 30, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and identifies AmerisourceBergen's Conshohocken, Pennsylvania location as the place of performance. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $16,213.24 delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for RINVOQ ER 30 mg tablets (30-count units) with a completion date of January 6, 2026. This is a firm fixed price, non-set-aside contract being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,492.16 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count bottles) on November 17, 2025, with an ultimate completion date of November 18, 2025. This firm fixed-price, non-set-aside delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $25,160.03 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of RINVOQ ER 30 mg tablets (quantity: 30 units). The contract is a firm fixed price delivery order with an ultimate completion date of August 28, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation. Performance will be...
- The Defense Logistics Agency awarded a $7,509.61 delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of RINVOQ ER 45 mg tablets (28-count units). This is a firm fixed-price, competitively awarded contract with an ultimate completion date of December 10, 2025, and performance location in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation, reflecting AmerisourceBergen's capability to compete in open federal procurement. This delivery order...